| CPC A01N 1/146 (2025.01) [A01N 1/12 (2025.01); A01N 1/126 (2025.01); A61J 1/065 (2013.01); A61J 1/10 (2013.01); A61L 27/306 (2013.01); A61L 27/58 (2013.01); B82Y 5/00 (2013.01); B82Y 30/00 (2013.01); B82Y 40/00 (2013.01)] | 16 Claims |

|
1. A blood storage container comprising:
a blood storage container object surface; and
cerium oxide nanoparticles (CeONPs) present in an amount to yield a concentration of CeNOPs of 10 nM to 100 nM in a blood, blood product(s), components thereof, or any combination thereof when stored in the blood storage container that is effective to (a) maintain an ATP concentration of at least 4.0 μmols/gHb in the blood, blood product(s), components thereof, or any combination thereof when stored in the blood storage container for 28 days at 4 degrees C. (b) maintain an ATP concentration of at least 2.8 μmols/gHb in the blood, blood product(s), components thereof, or any combination thereof when stored in the blood storage container for 42 days at 4 degrees C.; or (c) both (a) and (b) thereby increasing the useful storage life of blood, blood product(s), components thereof, or any combination thereof when stored in the blood storage container.
|